| 31 |
In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial |
2024 |
| 32 |
Prevalence and determinants of post-stroke psychosis in Aswan: a prospective study |
2024 |
| 33 |
Short-Term Therapeutic Effect of Repetitive Transcranial Magnetic Stimulations of Sleep Disorders in Parkinson’s Disease: A Randomized Clinical Trial (Pilot Study) |
2024 |
| 34 |
The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders |
2024 |
| 35 |
The impact of sex differences on stroke risk factors and 3-month outcomes in patients receiving thrombolytic therapy for acute ischemic stroke |
2024 |
| 36 |
The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease |
2024 |
| 37 |
The role of infections and inflammation in schizophrenia: review of the evidence |
2024 |
| 38 |
White matter lesion load and location in relation to cognitive impairment in relapsing– remitting multiple sclerosis |
2024 |
| 39 |
A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report |
2023 |
| 40 |
Cerebrovascular Changes and Multiple Sclerosis |
2023 |